Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2018 Filed Feb 13, 2018 18:58 UTC |
ANDERSON KERRII BDirector
|
SaleCommon Stock | 3,300 | $166.10 | $548,124.06 |
DisclosureSEC source: 0001127602-18-005411 · form4.xml · nonDerivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,095 Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:58 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionCommon Stock | 3,300 | $75.63 | $249,579.00 |
DisclosureSEC source: 0001127602-18-005411 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:55 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005410 · form4.xml · derivative · entry 6 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,491 Underlying: Common Stock · 3,047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:55 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005410 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,538 Underlying: Common Stock · 1,830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:55 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 913 | $168.08 | $153,457.04 |
DisclosureSEC source: 0001127602-18-005410 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,231 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:55 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 3,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005410 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:55 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 549 | $168.08 | $92,275.92 |
DisclosureSEC source: 0001127602-18-005410 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,097 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:55 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 1,830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005410 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005409 · form4.xml · derivative · entry 6 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,491 Underlying: Common Stock · 3,047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005409 · form4.xml · derivative · entry 5 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,538 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 913 | $168.08 | $153,457.04 |
DisclosureSEC source: 0001127602-18-005409 · form4.xml · nonDerivative · entry 4 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,429 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 3,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005409 · form4.xml · nonDerivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 135 | $168.08 | $22,690.80 |
DisclosureSEC source: 0001127602-18-005409 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,295 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005409 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:51 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005408 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:51 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 167 | $168.08 | $28,069.36 |
DisclosureSEC source: 0001127602-18-005408 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,505.9891 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:51 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005408 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,672.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:47 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005407 · form4.xml · derivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,578 Underlying: Common Stock · 520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:47 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 144 | $168.08 | $24,203.52 |
DisclosureSEC source: 0001127602-18-005407 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,284 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:47 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005407 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:46 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 603 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005406 · form4.xml · derivative · entry 3 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,795 Underlying: Common Stock · 603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:46 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 203 | $168.08 | $34,120.24 |
DisclosureSEC source: 0001127602-18-005406 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,236.6826 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:46 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 603 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005406 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,439.6826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:44 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005404 · form4.xml · derivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,061 Underlying: Common Stock · 7,543 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:44 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 3,138 | $168.08 | $527,435.04 |
DisclosureSEC source: 0001127602-18-005404 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,890.3298 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:44 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,543 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005404 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,028.3298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:56 UTC |
Schechter Adam HDirector
|
SaleCommon Stock | 1,263 | $169.29 | $213,813.27 |
DisclosureSEC source: 0001127602-18-004896 · form4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,034 F2 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:16 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004925 · form4.xml · derivative · entry 3 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,398 Underlying: Common Stock · 326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:16 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 129 | $169.66 | $21,886.14 |
DisclosureSEC source: 0001127602-18-004925 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,836.6826 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 17.4249 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:16 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004925 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,965.6826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 17.4249 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:13 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004918 · form4.xml · derivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,604 Underlying: Common Stock · 4,220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:13 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 1,264 | $169.66 | $214,450.24 |
DisclosureSEC source: 0001127602-18-004918 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,485.3298 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:13 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 4,220 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004918 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,749.3298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:11 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004915 · form4.xml · derivative · entry 3 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,927 Underlying: Common Stock · 1,863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:11 UTC |
Ratliff John DCEO, Covance Drug Development
|
Tax withholdingCommon Stock | 560 | $169.66 | $95,009.60 |
DisclosureSEC source: 0001127602-18-004915 · form4.xml · nonDerivative · entry 2 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,430 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:11 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionCommon Stock | 1,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004915 · form4.xml · nonDerivative · entry 1 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:09 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionRestricted Stock Unit · Derivative | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004914 · form4.xml · derivative · entry 6 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,961 Underlying: Common Stock · 630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:09 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionRestricted Stock Unit · Derivative | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004914 · form4.xml · derivative · entry 5 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,591 Underlying: Common Stock · 446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:09 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Tax withholdingCommon Stock | 188 | $169.66 | $31,896.08 |
DisclosureSEC source: 0001127602-18-004914 · form4.xml · nonDerivative · entry 4 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096.3653 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:09 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionCommon Stock | 630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004914 · form4.xml · nonDerivative · entry 3 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,284.3653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:09 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Tax withholdingCommon Stock | 141 | $169.66 | $23,922.06 |
DisclosureSEC source: 0001127602-18-004914 · form4.xml · nonDerivative · entry 2 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654.3653 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:09 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionCommon Stock | 446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004914 · form4.xml · nonDerivative · entry 1 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 795.3653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 993 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004905 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,368 Underlying: Common Stock · 993 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 299 | $169.66 | $50,728.34 |
DisclosureSEC source: 0001127602-18-004905 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,816 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 993 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004905 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:02 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 296 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004903 · form4.xml · derivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,098 Underlying: Common Stock · 296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:02 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 82 | $169.66 | $13,912.12 |
DisclosureSEC source: 0001127602-18-004903 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,908 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:02 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004903 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:01 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004901 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,794 Underlying: Common Stock · 246 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:01 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 92 | $169.66 | $15,608.72 |
DisclosureSEC source: 0001127602-18-004901 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,222.9891 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 37.8767 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.